ABSTRACT: Pediocin PA-1 is a broad-spectrum lactic acid bacteria bacteriocin that shows a particularly strong activity against Listeria monocytogenes, a foodborne pathogen of special concern among the food industries. This antimicrobial peptide is the most extensively studied class IIa (or pediocin family) bacteriocin, and it has been sufficiently well characterized to be used as a food biopreservative. This review focuses on the progress that have been made in the elucidation of its structure, mode of action, and biosynthesis, and includes an overview of its applications in food systems. The aspects that need further research are also addressed. In the future, protein engineering, genetic engineering and/or chemical synthesis may lead to the development of new antimicrobial peptides with improved properties, based on some features of the pediocin PA-1 molecule.
I. INTRODUCTION
Bacteriocins of lactic acid bacteria (LAB) are attractive to the food industry because they may be used as natural biopreservatives and contribute to the improvement of the microbiological quality of foods. 1 Also, the use of these ribosomally synthesized antimicrobial peptides may allow a significant reduction in the level of chemical additives and/or in the intensity of the physical treatments currently employed during food processing. Therefore, they could also help to provide healthier foods. 2 Since the late 1920s, when the first reports on the antimicrobial activity of a lactococcal bacteriocin (later called nisin) were made, a large number of LAB bacteriocins have been identified, particularly in the last few years. On a scientific basis, LAB bacteriocins can be divided into three main classes: 3, 4 class I (lantibiotics), class II (small heatstable nonlantibiotics), and class III (large heatlabile bacteriocins). Class IIa, one of the subgroups in which class II bacteriocins may be divided, is also termed the "pediocin family" after the first and most extensively studied representant of this class, pediocin PA-1. 4 Members of this subgroup ("pediocin-like" bacteriocins) show very strong antilisterial activity and have 40 to 60% sequence similarity ( Table 1 ). The N-terminal region is particularly well conserved and contains a conserved "pediocin box" motif (YGNGVXCXK). 5 Nisin is currently the only bacteriocin licenced as a food additive in over 45 countries. 6 However, several studies have shown that there are other LAB bacteriocins with potential for use as food preservatives, particularly class IIa bacteriocins due to their antilisterial activity. 7 In fact, the biopreservative potential of pediocin PA-1 has already been commercially exploited. The pediocin PA-1-containing fermentate Alta TM 2341 is a commercial food ingredient reported to extend the shelflife of a variety of foods and, particularly, to inhibit the growth of Listeria monocytogenes in ready-to-eat meat products. In the past, several pediocin PA-1-producing LAB strains were independently isolated in different labs. [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, in many cases the bacteriocin produced received different names (e.g., pediocins PA-1, AcH, JD, Bac and 347, mesentericin 5) before identification and realization that all were the same molecule. As it is desirable to conform to a uniform nomenclature, 1 the more widespread name, pediocin PA-1, has been adopted for this review.
Despite the fact that pediocin PA-1-producing LAB have been inadvertly or empirically used as starter cultures for many years, most of the current knowledge on pediocin PA-1 has been generated since 1992. In that year, the determination of the pediocin PA-1 amino acid sequence, [20] [21] the application of improved protocols for its purification, 21 and the identification of the pediocin PA-1 operon, [22] [23] greatly facilitated research on this subject. In addition, the continuous development of new and improved biotechnological tools have favored the increasing number of studies dedicated to this bacteriocin. The purpose of this article is to review the now enormous literature on an antimicrobial peptide with such industrial potential. Advances in the understanding of its structure, mode of action, and biosynthesis will be highlighted. Following that, we discuss the development of methods that allow its specific detection and quantification. The results of the studies involving application of pediocin PA-1 in food substrates will also be presented. Finally, the last part of this review exposes the main conclusions and future prospects of this interesting antibacterial peptide.
II. PHYSICOCHEMICAL PROPERTIES

A. Structure
The primary structure of pediocin PA-1 has been determined by Edman degradation of the purified peptide and by sequence analysis of the structural gene. [20] [21] [22] [23] Pediocin PA-1 is a 44 amino acid peptide with no postranslational modifications. [20] [21] The primary structure seems enough to induce toxicity on sensitive cells as synthetic pediocin is biologically active and has a specific activity comparable to that of the natural form. 24 Other remarkable characteristics of the molecule are the absence of phenylalanine, leucine, glutamine, or arginine residues and the presence of four lysine and three histidine residues and only one aspartate. Titration of free cysteine residues with Ellman's reagent, tryptic cleavage patterns, mass spectrometry data, and pediocin reduction in the presence of dithiothreitol (DTT) have provided evidence for the four cysteine residues forming two disulfide bonds (C 9 -C 14 and C 24 -C 44 ), 20, [24] [25] [26] which are also spontaneously formed in synthetic pediocin PA-1. 24 As a reflection of its amino acid composition and sequence, pediocin PA-1 is a cationic peptide with a basic pI. Values ranging from +7 to +3 have been reported for the net charge at pH 6, 1, 27, 28 and from 8.6 to 10 for the pI. 1, 20, 21, 29 A comparison of the primary structures of the pediocin-like bacteriocins suggests that their polypeptide chains can be divided into two functional modules, a conserved hydrophilic N-terminal β-sheet and a more diverse hydrophobic or amphiphilic C-terminal α-helical domain 24, 30 (Table 1) .
Initially, the secondary structural organization of the peptide was predicted by Henderson et al. 20 following primary sequence analysis by ChouFasman and Kyte-Coolite protocols. It is proposed that the structure would consist of random coils and β-turns with a propensity of residues A 21 through I 25 for a β-sheet and a primarily hydrophilic profile except for the predicted β-sheet area. In addition, the fragment T 22 to A 34 that contains the single tryptophan and methionine residues would define a hydrophobic region in close spatial proximity with the C-terminus due to the disulfide bond C 24 -C 44 .
More recently, Chen et al. 27 predicted the pediocin PA-1 secondary structure on the basis of single and multiple sequence alignments and built a model for its 19 N-terminal amino acids. The model consisted of two β-strands connected by a tight 4-residues β-hairpin. The N-terminal β-turn would include the consensus sequence (YGNGV) of class IIa bacteriocins, and the tip of the β-hairpin would contain two positively charged residues (K 11 and H 12 ). The C 24 -C 44 disulfide bond would bring together H 42 , K 43 , and possibly K 20 . NMR data had previously shown an ordered β-structure in the vicinity of the two cysteine residues (C 9 and C 14 ) of leucocin A, another class IIa bacteriocin. 31 Figure 1 shows a model of the pediocin PA-1 structure.
B. Molecular Weight
The theoretical molecular weight of pediocin PA-1, calculated from the amino acid sequence, could be 4628 or 4624 Da, in the absence or presence of two disulfide bonds, respectively. 20, 24 Experimental determination of the molecular weights of natural and synthetic pediocin by electrospray mass spectrometry revealed that the cysteine residues are oxidized and joined by two disulfide bonds. 16, 17, 24 Previously, a molecular weight of approximately 16 ,500 had been estimated by gel filtration of a partially purified sample. This value was nearly an exact multiple of the actual molecular weight, suggesting the presence of a stable tetramer. 8 
C. Solubility and Stability
The fact that many studies on pediocin PA-1 solubility and stability have been performed with partially purified samples makes it difficult to directly compare results obtained by different authors.
Pediocin PA-1 is stable in dilute aqueous solutions, although the molecules can form active aggregates and tend to do so more readily as the pediocin concentration increases and at refrigeration temperatures. 10 Aggregation seems to involve components of the growth medium rather than being an autocatalytic process because in contrast to pediocin PA-1 in supernatants or to partially purified samples, the homogeneous peptide does not aggregate even at high concentrations. 20 Samples containing pediocin PA-1 retained total or partial activity after exposure for 24 h to pH values ranging from 2 to 10 at room temperature, although the highest stability was achieved between pH 4 and 6. 8, 10 Evaluation of the residual activity after storage at 15°C of a culture extract from Lb. plantarum WHE 92 showed that pediocin PA-1 was perfectly stable after 21 days when the pH of the extract was mantained at 4, 5, or 6, but half of the activity dissapeared at pH 7. 17 Although antimicrobial activity was unaffected by heating at 80°C for 60 min and at 100°C for 10 min, the effect of a treatment at 121°C for 15 min is controversial as values of residual activity of 6% 8 and 60% 10 have been reported. Freezing (-25°C) or refrigeration (0 to 8°C) storage did not reduce the activity of pediocin samples after 6 months and 12 weeks, respectively. 32 In contrast, activity was stable at room temperature (22 to 25°C) for 6 weeks, but then it progressively decreased and over 50% was lost in 12 weeks. 32 Recently, it has been shown that purified pediocin PA-1 stored at 4 and 25°C is stable at pH 5 but not at pH 7, while it remains stable after storage at -20°C at both pH values. 33 Pediocin PA-1 activity is unaffected by treatment with phospholipase C, catalase, lysozyme, Dnases, Rnases, or lipases but is lost after incubation with proteolytic enzymes such as trypsin, papain, ficin, α-chimotrypsin, protease IV, protease XIV, protease XXIV, and proteinase K. 8, 10, 34 Pediocin activity rapidly decreased when monitored in a culture of Lb. plantarum WHE 92, most probably because of hydrolysis by proteolytic enzymes produced at the end of the exponential growth phase. 17 As a result, the percentage of residual activity ranged from 1 to 6% after 21 days of incubation at 15°C. The absence of contaminating proteases may also explain why synthetic pediocin is more stable than the molecule isolated from the natural source. 24 After storage in 30% acetonitrile-0.1% trifluoroacetic acid (TFA) for 1 week or more at -15°C, pediocin molecules became oxidized, showing a molecular weight increase of 16 or multiples of 16. 16 Similarly, after storage in 30% 2-propanol-0,1% TFA for 8 months at 4°C, about 50% of natural and synthetic pediocin had been transformed to a more hydrophilic and less active form (pediocin PA-1-ox). 24 The pediocin PA-1-ox molecular weight had increased by 16 relative to that of pediocin PA-1 and had suffered a 100-to 200-fold reduction in its specific activity. The oxidation of the sulfur atom of the methionine residue of pediocin PA-1, and its transformation to sulfoxide in the pediocin PA-1-ox molecule may explain the increase in molecular weight and hydrophilicity without charge alteration. 24 Recently, site-directed mutagenesis studies were performed to obtain methionine-free pediocin PA-1 variants. 33 Although mutating Met 31 to Asp nullified bacteriocin activity, other methionine-free pediocin PA-1 variants (Met 31 to a hydrophobic amino acid, such as Ala, Leu, or Ile) displayed higher storage stability without a concomitant large loss of activity.
D. Purification
Because pediocin PA-1 is a secreted peptide, most of the purification protocols start with the concentration of cell-free supernatants obtained from the producing strains prior to the application of chromatography-based techniques.
Initially, Gonzalez and Kunka 8 partially purified pediocin PA-1 by ammonium sulfate precipitation and two successive ion-exchange chromatographic steps of the reconstituted dialyzed precipitate. However, no data were provided on the evolution of the specific activity through the purification process. After a similar precipitation step, Bhunia et al. 10 employed gel filtration and anion-exchange chromatographies, both integrated in an FPLC system. The activities of the final fractions were up to 98 times higher than those of the respective supernatants.
The ability of this bacteriocin to adsorb to the cell envelope of the producing cells was the basis of the purification method developed by Yang et al. 35 These authors adjusted the pH of a fully grown culture to pH 6, a value coincident with the highest adsorption efficiency. Then, cells were collected by centrifugation and the pH of the cell suspension was readjusted to 2 for bacteriocin release. The suspension was applied to a reverse-phase column coupled to an HPLC system and 106% of the initial activity was recovered Daba et al. 16 followed a similar approach and the elution profile revealed two peaks with antimicrobial activity. The large HPLC peak corresponded to pediocin PA-1, while the minor peak contained oxidized forms of the bacteriocin.
In 1992, Henderson et al. 20 purified pediocin PA-1 to homogeneity by sucessive gel filtration of the supernatant, ion-exchange chromatography, dialysis and, finally, reverse-phase chromatography coupled to HPLC. Although the yield was only 0.6%, the final sample was pure enough to allow pediocin PA-1 amino acid sequencing. Simultaneously, Nieto-Lozano et al. 21 also purified this bacteriocin to homogeneity and sequenced it. Their purification procedure, with a significantly higher activity yield (600%), included ammonium sulfate precipitation, followed by three chromatographic steps (cation-exchange, hydrophobic interaction, and reverse-phase chromatography, respectively). [36] [37] This basic protocol, with slight modifications, has been widely and successfully applied for the purification of a large number of LAB bacteriocins. Usually, the final reverse-phase chromatography step is repeated two or three times to ensure maximum purity. In addition, the use of large volumes of washing buffer for the washing steps during ion-exchange and hydrophobic interaction chromatographies may contribute considerably to purity, 26 while a gel filtration step prior to the cation-exchange chromatography may increase the purification yield. [38] [39] [40] [41] Recently, 42 another chromatographybased method consisting in three steps (ion-exchange, solid phase extraction, and reverse phase HPLC) has been applied successfully to obtain highly pure class IIa bacteriocins, including pediocin PA-1.
Pediocin PA-1 has also been purified by a protocol, including ethanol precipitation, preparative isoelectric focusing, and ultrafiltration. 29 About 32% of the pediocin contained in the culture supernatants was precipitated with cold ethanol. Almost no activity (3%) was lost during isoelectric focusing and all activity remained after ultrafiltration. The major advantage of this method was the omission of chromatography steps, avoiding losses due to bacteriocin sticking to the matrix of the columns.
Ideally, the methods used for bacteriocin purification should have high final yields, low costs, and a high reproducibility. The purification protocols cited above involve several steps that make the process inefficient, laborious, and/or expensive, especially if scaling-up for industrial purposes is desired. Construction of immunoaffinity columns using pediocin PA-1-specific-antibodies may constitute an alternative approach for the simple (even singlestep) purification of pediocin PA-1. Nisin monoclonal antibodies 43 were used successfully for the one-step purification of this lantibiotic in 5 ml immunoaffinity columns, although scaling-up has not been evaluated yet. 44 In this context, the recent generation of polyclonal antibodies that specifically recognize pediocin PA-1 is a promising step. 40, 41 
III. BIOLOGICAL PROPERTIES
A. Antimicrobial Spectrum
Pediocin PA-1 displays antimicrobial activity against a wide spectrum of Gram-positive bacteria, many of them responsible for food spoilage or foodborne diseases. The activity of pediocin PA-1 against Listeria monocytogenes, a microorganism with the highest mortality rate among foodborne bacteria in Western Europe and North America, is particularly relevant. Therefore, many studies on the biological activity of this peptide have been focused on its effects on L. monocytogenes cells. 45 Interestingly, pediocin PA-1 is not active against bacteria used frequently in starter cultures, such as lactococci. Pediocin PA-1 has similar MIC values at 20, 30, and 37°C, and its C-terminal disulfide bridge is a major determinant of the antimicrobial spectrum. 46 The structure and composition of the outer membrane of Gram-negative bacteria do not allow pediocin access to its target, the cytoplasmic membrane. However, many Gram-negative organisms (such as Salmonella typhimurium, Escherichia coli, Serratia liquefaciens, and Pseudomonas fluorescens strains) are pediocin PA-1-sensitive after inflicting sublethal injuries (like freezing, gentle heating, exposure to lactic acid or EDTA, or hydrostatic-pressure pasteurization) to the outer membranes, rendering their cytoplasmic membranes accessible to pediocin molecules. [47] [48] [49] [50] [51] 
B. Quantification of the Antimicrobial Activity
Currently, the agar diffusion test is one of the most widely used methods to detect bacteriocin activity. Several arbitrary units have been defined to quantify the antimicrobial activity of pediocin PA-1 on solid media. Bhunia et al. 10 employed "antimicrobial activity units" (AAU) calculated as the reciprocal of the antimicrobial titre multiplied by the dilution factor and divided by the protein concentration (in mg) determined by the Lowry method. The titre was defined as the reciprocal of the highest dilution producing a clear zone of inhibition of 2 mm or larger on an Lb. plantarum WSO-39 lawn. 52 Later, Gonzalez and Kunka 8 defined one "arbitrary unit" (AU) of bacteriocin as 5 µl of the highest dilution of culture supernatant yielding a definite zone of growth inhibition on a lawn of the indicator P. pentosaceus FBB63. This unit was also adopted by other authors. 20, [53] [54] [55] Turbidometric methods, such as the microtitre plate assay, 36, 56 are also used to detect and quantify pediocin activity. 19, 21, [38] [39] [40] In this system, one bacteriocin unit (BU) is defined as the reciprocal of the sample dilution, which inhibits growth of the indicator organism by 50%, as indicated by spectrophotometric measures. This method is very useful to evaluate the activity of the different fractions obtained during pediocin PA-1 purification.
In contrast to nisin, there is no international unit refering to the activity of an international reference sample of pediocin PA-1. It is impossible to compare arbitrary antimicrobial activity values in cultures, culture supernatants, or (partially) purified pediocin PA-1 obtained by different authors, even if they use the same assay, because the MICs values for vegetative cells and spores may significantly differ depending on the producing or indicator strains, the sample preparation method, and the bacteriocin assay conditions. 57 In addition, the major drawback of the assays cited above is their unspecificity. In this context, the recent development of pediocin PA-1 specific polyclonal antibodies enables the specific quantification of the pediocin present in a sample by using a wide array of immunoassay formats. 40, 41 Detecting a specific bacteriocin by searching for a compound with a determined molecular mass may be a practical approach to confirm the presence of pediocin PA-1 in cultures or foodstuffs.
Matrix-assisted laser desorption/ionization timeof-flight mass spectrometry (MALDI-TOF MS) has been used recently for rapid detection of pediocin PA-1, nisin, brochocins A and B and enterocins A and B, from culture supernatants. 58 Compared with other spectrometric techniques, MALDI-TOF MS offers some advantages for the routine analysis of bacteriocins, including ease of use, picomolar to femtomolar sensitivity, high mass range, ability to give extremely accurate mass values, and relative tolerance to sample contaminants. 58 
C. Resistance to Pediocin PA-1
The emergence of organisms highly tolerant or naturally resistant to class II bacteriocins has become quite common and is a potential obstacle to their application as food biopreservatives. 59 Although the ecology and mechanisms of resistance to many traditional antibiotics have been studied profusely, little is known on these aspects in the bacteriocin field. 60, 61 However, investigations on this subject will rapidly increase in the near future because of the industrial interest in the application of bacteriocins and/or bacteriocinogenic LAB to improve the microbiological quality of foods.
Sensitivity to pediocin PA-1 differs greatly between species and strains evaluated, 18, 59, 62 atlhough pediocin PA-1-resistant or -tolerant strains seem to occur more frequently than strains displaying resistance or tolerance to nisin. 59 Growth of surviving cells of L. monocytogenes strains in pediocin PA-1-treated foods during refrigeration storage (4 and 10°C) has been reported, 53, 62 and the population levels of some strains reached very high numbers in a short time, 62 even in the presence of residual pediocin. As reduction in Listeria counts was greater with higher levels of pediocin, it has been suggested that the level of pediocin (or other bacteriocins) should be adjusted to obtain maximum viability loss of the most resistant strain when used as a food preservative. 62 Probably, the routine use of pediocin PA-1 at concentrations not high enough to eradicate all Listeria cells may result in emergence of populations resistant not only to pediocin but also to other closely related bacteriocins. 63 The effect of pediocin was higher when the initial Listeria population was lower, 62 a fact confirmed by a later study that showed complete inhibition of Listeria cells on refrigerated chicken meat by pediocin treatment. 64 These results emphasize the importance of effective measures to prevent or minimize food contamination.
Noerlis and Ray 65 described how a nonpediocin producer P. acidilactici strain (obtained after loss of the plasmid harbouring the pediocin PA-1 operon) became resistant to this bacteriocin while growing in its presence. However, this study also indicated that the acquired resistance was a transient trait because it was soon lost after subculturing (five subcultures) in a pediocin PA-1-free medium. Similarly, Dykes and Hastings 61 studied the fitness costs associated with class IIa bacteriocin resistance in one L. monocytogenes strain and found that the resistant strain had a lower growth rate than the sensitive one in monocultures, and, furthermore, that resistant cells were unable to invade populations of the sensitive variants when grown in mixed cultures. The authors concluded that this specific class IIa bacteriocin resistance was unlikely to become stable in natural populations of that particular L. monocytogenes strain. However, this study may not reflect the general situation because only one resistant strain was tested. In contrast, the resistance to other LAB bacteriocins has been shown to be stable during at least 10 generations in the absence of contact with bacteriocins. 66 Involvement of cell wall constitution and membrane lipid composition in acquired bacteriocin resistance has been suggested frequently. [67] [68] [69] [70] The fact that stability of the resistance phenotype can vary and may or may not be lost after subculturing in the absence of the bacteriocin indicates that a more general adaptive response may also be involved in trained bacteriocin resistance. 18 Bennik et al. 18 studied the relationships between membrane lipid properties and the effect of pediocin PA-1 and nisin on glycolysis, intracellular ATP pools, and membrane potential of whole LAB cells. Their results indicate that not only membrane lipid composition, but also overall membrane constitution may play an important role in determining LAB susceptibility toward these bacteriocins. These authors suggested that although LAB strains with a natural high resistance toward a bacteriocin cannot avoid the membrane insertion of bacteriocin monomers, the overall composition of the membranes may preclude the formation of pores with sufficient diameters and lifetimes to cause cell death (see mode of action).
Combination of pediocin PA-1 with other bacteriocins may constitute one approach to avoid the growth of resistant cells. A mixture of nisin and pediocin PA-1 was bactericidal to more cells in an initially sensitive population, probably because cells resistant to one bacteriocin were killed by the other. 71 The combination killed more cells of two LAB and two L. monocytogenes strains than each bacteriocin individually. In addition, the mixture inhibited growth of all clostridial strains tested for up to 28 days, while pediocin or nisin alone produced variable results. Recently, the additive effect of applying pediocin PA-1 in combination with bacteriocins belonging to unrelated classes has been reported, 72 demonstrating that, in addition to nisin A, it can acts synergistically with lacticin 481, lacticin B, or lacticin F. In contrast, when pediocin PA-1 was combined with other class IIa bacteriocins, no synergistic effects were observed. 26 The fact that pediocin PA-1 is, structurally and functionally, completely unrelated to nisin, lacticin 481, lacticin B, or lacticin F may have practical consequences. Different authors 59, 66 have reported that although L. monocytogenes mutants with spontaneously acquired resistance to one class II bacteriocin also displayed cross-resistance to other members of this bacteriocin class, their sensivity to nisin had not been affected. Sakacin P (a class IIa bacteriocin) sensitivity among 22 strains of L. monocytogenes directly correlated with the pediocin PA-1 sensitivity of the strains. In another study, 63 Listeria cells surviving nisin action were pediocin PA-1 resistant, while pediocin PA-1 survivors remained susceptible to the lantibiotic. The beneficial synergistic effects resulting from the combination of unrelated LAB bacteriocins can be exploited to extend their potential application in the food industry.
D. Mode of Action
The bactericidal mode of action of pediocin PA-1 on sensitive cells involves three basic steps: pediocin binding to cytoplasmic membranes, insertion of bacteriocin molecules in the membranes, and formation of the poration complex. This process finally leads to cell death that may occur with or without cell lysis, probably depending on concomitant activation of the cell autolysins. For a review on the mechanism of action of pediocin PA-1 see Reference 73.
Initially, Gonzalez and Kunka 8 showed that pediocin-sensitive or pediocin-insensitive Grampositive cells adsorbed comparable levels of the bacteriocin and concluded that the specificity of pediocin PA-1 was at least not enterely dependent on the presence of specific receptor sites in sensitive cells, and that pediocin might have a high surface binding capacity responsible for the unlethal binding to insensitive bacteria. Bhunia et al. 54 reported that the bacteriocin did not bind to the cell surface of Gram-negative bacteria. Although the presence of lipoteichoic acid in the cell wall of Gram-positive bacteria and its absence in Gram-negative bacteria could explain this differential adsorption ability, it did not provide any explanation for the existance of sensitive and insensitive Gram-positive bacteria. These authors 54 also described how pediocin PA-1-treated sensitive cells lost intracellular K + ions and ultraviolet absorbing material became more permeable to ONPG and in some cases lysed.
The proton motive force (PMF) constitutes a key parameter in the understanding of the mode of action of LAB bacteriocins because it is required for many of the cells energy-dependent metabolic processes. The PMF is the result of the electrochemical gradient of protons across the bacterial cytoplasmic membrane and is composed of the membrane potential (∆ψ) and the pH gradient (∆pH). 74 The development of artificial membrane systems and techniques that allow the separate study of both components of the PMF have enabled the investigation of the effects of different bacteriocins, including pediocin PA-1, on PMF. Christensen and Hutkins 13 provided the first evidence for the involvement of PMF in the mechanism of action of pediocin PA-1. Pediocin caused a concentration-dependent dissipation of the PMF of L. monocytogenes Scott A cells. In addition, the peptide increased the membrane permeability of Listeria cells to protons, which agrees with a dissipation of the pH gradient.
These results, together with those obtained with nisin, [75] [76] [77] [78] [79] lactococcin A 80 , and lactococcin B, 81 led Bruno and Montville 82 to hypothesize that LAB bacteriocins employ a common mechanism of action based on the dissipation of the PMF of sensitive cells. To obtain further evidence, these authors 82 also investigated the influence of pediocin PA-1, nisin, lactacin F, and leuconocin S on the PMF of L. monocytogenes Scott A cells. During the assay period, the Listeria population decreased by 4 orders of magnitude after the addition of pure pediocin (20 µg ml -1 ) to the cultures. Additionally, the residual ∆ψ (-30 mV) was insufficient for culture viability. Energized cells lost their PMF in a concentration-dependent manner, while the ∆pH component was dissipated by a pediocin concentration lower than that required to eliminate ∆ψ. PMF collapse led to growth inhibition and death because of the low intracellular ATP levels and the inability to carry out active transport of nutrients and to maintain sufficient concentrations of cofactors, such as K + and Mg 2+ . Pediocin PA-1, lactacin F, and leuconocin S acted in an energy-independent manner, in contrast with the energy-dependent mode of action of nisin, a bacteriocin that seems to require a threshold membrane potential for activity. [82] [83] The independent studies of Bruno and Montville 82 and Chikindas et al. 25 indicated that pediocin PA-1 formed voltage-independent pores on the cytoplasmic membranes of target cells, a process that dissipated the transmembrane electrical potential, inhibited amino acid transport and caused an efflux of small ions. Their data also indicated that the pediocin concentration determined the size exclusion limit of the pores since more pediocin was required to release compounds having higher molecular weights (up to 9400). Although pediocin (in vitro and at high concentration) worked in the absence of PMF, the possibility that in vivo PMF could increase the efficiency of low pediocin concentrations on the target membranes was not excluded. On the basis of these and previous results, the authors proposed a model for the mechanism of action of pediocin PA-1. Initially, pediocin molecules would nonspecifically adhere to the cell surfaces, followed by specific binding to receptor components of the cytoplasmic membrane. Then, pediocin molecules would insert into the membrane, aggregate and form oligomeric structures, leading to hydrophilic pores through which ions and small molecules would be released from sensitive cells and, ultimately, to cell death. However, in the same study, 25 it was found that pediocin binds and inserts in E. coli lipid vesicles with a high content of zwitterionic phospholipids but without a protein receptor.
A study on the in vivo effect of pediocin PA-1 on L. monocytogenes confirmed that, concomitant with cell death, the bacteriocin induced depletion of cytoplasmic ATP and irreversible K + and phosphate efflux. 84 Pediocin PA-1 depleted 90% of cytoplasmic ATP when only 25% phosphate efflux had occurred, which indicated that loss of ATP was due to attempts of the cell to maintain PMF rather than its inability to produce ATP because of phosphate loss. In contrast, nisin causes simultaneous total ATP depletion and phosphate efflux. [85] [86] Chen et al. 28 characterized the physicochemical interactions of pediocin PA-1 with target membranes using two-lipid vesicle models, one based on total L. monocytogenes lipids and the second on synthetic phospholipids. The antimicrobial peptide caused a time-and concentrationdependent release of carboxyfluorescein (CF) from the vesicles. The CF efflux rates were higher in acidic that in neutral or alkaline conditions and depended on both pediocin and lipid concentrations. Although pediocin PA-1 was able to permeabilize the membrane of Listeria lipid vesicles in the absence of ∆ψ, the presence of a transmembrane potential (inside negative) increased the CF efflux rate by 88%. In vivo and in vitro energy-enhanced action has been previously reported for bavaricin MN, another class IIa bacteriocin, using the same lipid vesicle model. 87 Generation of ∆ψ could have stimulated the formation of more and bigger pores on the target membranes. 28 The fact that both lipid vesicle systems were devoid of membrane protein receptors, together with the pediocin concentration-dependent CF leakage, strongly suggested that no protein receptor was required for the recognition and binding of pediocin PA-1 to the membrane of sensitive cells. Instead, the bacteriocin molecules could have recognized specific membrane lipids and/or established electrostatic interactions with the phospholipid head groups.
As anionic phospholipids are the principal components of L. monocytogenes membranes, 88 Chen et al. 28 subsequently characterized the binding of pediocin and pediocin fragments to vesicles of phosphatidylglycerol by using tryptophan fluorescence as a probe. It is possible to differentiate tryptophan residues bound to membranes from those in peptide molecules in an aqueous solution because spectral parameters of its fluorescence emission change with environmental polarity. The results revealed that at least one tryptophan residue of pediocin PA-1 was inserted into the anionic membranes. This work also provided the first evidence fot the key role that electrostatic interactions between putative positively charged pediocin patches and the negatively charged phospholipid heads of the membranes play in the initial binding of the bacteriocin to target membranes.
A further study 89 revealed that affinity of pediocin PA-1 for phospholipid vesicles increases as the content of negatively charged phospholipids is higher. In addition, the relative dissociation constant for the peptide-lipid interaction was higher when the anionic lipid content of the vesicles decreased. This fact reflected the anionic lipid dependency of the initial binding to the membrane and supported the electrostatic interaction model of binding. Similar results have been obtained for the lantibiotics epilancin K7 83 and nisin. 83, 90 In addition to the initial unspecific electrostatic interactions, there are important specific interactions between the C-terminal half of pediocin PA-1 and the target cells, 24 particularly within the fragment spanning residues 20 to 34 30 (see structure-funcion relationships).
Bennik et al. 18 reported that the exposure of sensitive and insensitive LAB strains to pediocin PA-1 resulted in a similar concentration-dependant dissipation of ∆ψ, but the perturbation of the cytoplasmic membrane caused rapid ATP depletion only in the sensitive cells. These authors suggested that not only membrane fluidity (related to lipid composition), but overall membrane composition would influence the pore-forming activity of bacteriocins, as membrane proteins may affect lipid ordering.
E. Structure-Function Relationships
Despite the fact that class IIa bacteriocins have similar primary structures, their antimicrobial spectra show differences greater than what would be expected from the interaction between the cationic peptides and the membrane lipids. 5 Therefore, establishment of structure-function relationships constitutes one of the major challenges in bacteriocin research. To facilitate the understanding of this section, Figure 1 shows a schematic representation of the pediocin PA-1 structure-function relationships that are (putatively) known at present.
Several groups have described the loss of pediocin PA-1 antimicrobial activity as a consequence of DTT reduction of its disulfide bonds. 25, 73 DTT-induced reduction had only a moderate effect on curvacin A and sakacin P activities. 26 In these bacteriocins only the equivalent of the first pediocin PA-1 disulfide bond (C 9 -C 14 ) is present. Thus, the second disulfide bond (C 24 -C 44 ) in pediocin PA-1 seems to be essential for the biological activity of the peptide. This has been shown for the equivalent C 25 -C 43 disulfide bond in the class IIa bacteriocin divercin V41. 91 The fact that pediocin PA-1 and enterocin A (both with two disulfide bonds) are more active than curvacin A and sakacin P (with only one bond) may be due, at least partly, to the extra disulfide bond. 26 These studies suggest that the conserved bond is important but not crucial for antimicrobial activity. Similar findings have been reported with carnobacteriocin B2 92 and leucocin A, 93 but not with mesentericin Y105. 94 In fact, the activity of a mesentericin variant, which had the C 9 and C 14 residues substituted by serine residues, was notably lower than that of the native peptide. Some authors claim that both disulfide bridges are essential for pediocin PA-1 activity because of their supposed role in the maintenance of a conformation compatible with activity. 83, 94 The primary structure of class IIa bacteriocins may be divided into two functional regions, the well-conserved and hydrophilic N-terminal half and the more heterogeneous and relatively hydrophobic C-terminal half. 24 Fimland et al. 24 synthesized four hybrid bacteriocins in which the modules corresponding to pediocin PA-1 (Ped), sakacin P (Sak), and curvacin A (Cur) had been exchanged. The four hybrids (Ped-Sak, Sak-Ped, Cur-Sak, and Sak-Cur) were biologically active. The hybrid bacteriocin had an inhibition spectrum that was similar to that of the bacteriocin from which its C-terminal module was derived and different from the bacteriocin that provided the N-terminal part. Therefore, the C-terminal module of class IIa bacteriocins plays an important role in determining the specificity of target cells. A later report 30 indicated that a 15-mer peptide fragment derived from pediocin PA-1 (residues 20 to 34) interfered specifically with pediocin PA-1 target cell interaction, leading to inhibition of the pediocin antimicrobial activity. The fragment also significantly affected enterocin A activity but not that of other closely related bacteriocins (sakacin P, curvacin A, and leucocin A). Among these bacteriocins, pediocin PA-1 and enterocin A have the highest degree of homology in the region spanned by the fragment and, additionally, are the only ones with a cysteine residue in this region. Apparently, inhibition of pediocin PA-1 activity by the fragment was due to specific interference of the fragment with pediocin-target cell interactions and not merely to hydrophobic interactions between these two elements. Recently, site-directed mutagenesis studies of pediocin PA-1 and sakacin P have been performed to elucidate the structural basis for the differences observed in their respective activities and target cell specifities. 46 By making the primary structure of sakacin P more pediocin PA-1-like, it has been shown that the extra disulfide bond C 24 -C 44 of pediocin PA-1 contributes to both temperature stability and to widening the target cell spectrum. The results also support the previous suggestion 24, 30 that the variable C-terminal part of pediocin-like bacteriocins interacts with the hydrophobic part of the membrane, being an important determinant of target cell specificity.
Chen et al. 28 observed that K 11 and H 12 residues were essential in the bacteriocin binding to phospholipid vesicles. At pH 6, two pediocin fragments, N15 (residues 1 to 15) and N8-15 (residues 8 to 15), bound strongly to lipid vesicles and the binding behavior of N15 was comparable to that of pediocin PA-1. However, the binding ability displayed by fragment N7 (residues 1 to 7), which do not contain the positively charged residues, was only weak. In addition, no binding was observed at the same pH value using the mutant N m 8-15, in which K 11 and H 12 had been replaced by uncharged residues (I 11 and L 12 , respectively). Binding of the fragments containing this putative positive patch decreased by adjusting the pH to 8, probably because of the deprotonation of the histidine residue.
The finding that an in-frame fusion between the functional mature domain of pediocin PA-1 and the C-terminus of the secretory protein maltose-binding protein (MBP) retained antimicrobial activity 96 suggests that the bacteriocin N-terminal region does not span the phospholipid bilayers of the target cells. The same study revealed that the class IIa consensus sequence is essential for pediocin PA-1 activity because its deletion resulted in loss of the activity.
Miller et al. 97 generated a collection of 18 pediocin mutants, 17 of which were obtained by random PCR mutagenesis of the pediocin PA-1 structural gene. They were produced and secreted as MBP-fusion proteins. Eight mutants (N5K, C9R, C14S, C14Y, C24S, G37E, G37R, and C44W) were completely inactive, while nine (K1N, W18R, I26T, M31T, A34D, N41K, H24L, K43N, and K43E) retained some activity, ranging from <1 to 60%. However, the activity of the remaining mutant (K11E) was around 2.8-fold higher than that of the MBP-pediocin PA-1 chimeric protein. The results showed that the four cysteine residues were required for activity. The disulfide bond may be essential to maintain the conformation of the sequence G 10 -K 11 -H 12 -S 13 that constitutes the apex of the β-hairpin previously proposed by Chen et al. 27 and that exhibited weak homology to several known types of consensus β turns. Among the four lysine and three histidine residues of pediocin PA-1, three residues (K 1 , H 42 , and K 43 ) seemed to be particularly important for activity. 96 The substitution K1N resulted in an almost complete inactivation of bacteriocin activity, while the substitutions H42L, K43N, and K43 reduced its activity by 40 to 80%. Therefore, K 1 may play an essential role in membrane binding while that of H 42 and K 43 would be secondary. These results 97 show that protein engineering of class IIa bacteriocins could be a feasible way to improve their activity, stability, and/or solubility.
Miller et al. 97 submitted the pediocin C-terminal half to hydrophobicity analysis in order to locate apolar sequences that could participate in membrane binding. In this region, the stretch comprising residues I 25 to G 37 had enough hydrophobicity to allow its location inside a phospholipid bilayer if simultaneous membrane insertion of two or more molecules would occur, something that probably does occur during the formation of the poration complex.
It has been suggested that the C-terminal module of pediocin PA-1 would become amphiphilic, and therefore would permit the formation of a poration complex if it adopted a transmembrane α-helical secondary structure. 24 However, adoption of such a structure seems incompatible with the disulfide bond C 24 -C 44 formed by residues located at the begining and end of such an α-helix. 26 The effect of this disulfide bridge in the structure of the C-terminal region will have to be determined before drawing any conclusion on the role of amphipathicity, if any, in the formation of the poration complex. 97 
IV. BIOSYNTHESIS
A. Location of the Genetic Determinants
The genetic determinants for the biosynthesis of pediocin PA-1 are plasmid encoded in all producing strains isolated to date. 8, 11, 15, [17] [18] [19] 23, 34, 98, 99 In several strains, the sizes, organization, and restriction profiles of the various pediocin-encoding plasmids are similar. 17, 100 It has been shown that the plasmids responsible for production in P. acidilactici H can be transferred intragenerically by conjugation. 34 
B. Organization of the Pediocin PA-1 Operon
Pediocin PA-1 biosynthesis involves a DNA fragment of approximately 3.5 kb, comprising the four genes pedA, pedB, pedC, and pedD. 22 Each gene is preceded by a ribosome binding site (RBS), starts with the AUG start codon (except pedB, which starts with a UUG codon), and finishes with a UAG stop codon 22 (Figure 2) . The four genes are organized in a single operon, governed by a promoter located directly upstream of pedA. The sequences of its -35 (TTGACA) and -10 (TAGAAT) regions, separated by 18 bp, are in close agreement with the consensus sequences of constitutive promoters of Gram-positive bacteria. 22, 101 Two transcripts are produced from the pediocin PA-1 operon. The most abundant messenger has a size of approximately 1.2 kb and covers pedABC, while the second transcript has a size of 3.5 kb and corresponds to the pedABCD genes. 55 There are rho-independent transcriptional terminators directly downstream of the pedC and pedD genes 55, 102 (Figure 2) .
The production of some class II bacteriocins has been reported to be a quorum sensing phenomenon. 103 The process is transcriptionally regulated through a signal transduction system integrating an induction factor (peptide pheromone), a histidine protein kinase and a response regulator. The induction factor is a bacteriocin-like peptide with a double-glycine leader but without bacteriocin activity. 4 There is no evidence for the existence of a similar system for the activation of transcription of the pediocin PA-1 genes.
C. The pedABCD Genes and Their Products
The pediocin PA-1 structural gene (pedA) encodes a 62 amino acid pediocin precursor called prepediocin PA-1. The 18 N-terminal residues of prepediocin constitute the leader sequence, which is removed concomitantly with secretion, resulting in mature pediocin PA-1, a peptide of 44 amino acids. The pediocin leader belongs to the group of the "double-glycine" leaders, which is found in most nonlantibiotic and some lantibiotic LAB bacteriocins and also in colicin V from E. coli. These leaders share the consensus sequence L -12 S -11 XXE -8 L -7 XXI -4 XG -2 G -1 with the two conserved glycine residues at positions -1 and -2 constituting a common processing site, a fact reflected in the name of the group. 3, 104, 105 Prepediocin PA-1 is also biologically active, 55 approximately 80% as active as the mature bacteriocin. 106 Marugg et al. 22 suggested that the 112 amino acid protein encoded by pedB could be involved in immunity of the producing cells, because mutational inactivation of this gene did not affect pediocin PA-1 production in E. coli, a microorganism naturally insensitive to this bacteriocin. Later, this hypothesis was confirmed as pediocin PA-1 was not active against a previously sensitive P. pentosaceus strain that had been transformed with a plasmid carrying the pedB gene. 55 In fact, the level of insensitivity of the resulting strain was even higher than that of the parental producer, probably because of the higher copy number of the plasmid encoding pedB in the transformant and/or because pedB was cloned under the control of P32, a strong lactococcal promoter.
Recently, several immunity proteins belonging to pediocin-like bacteriocins were cloned behind P32. 107 Introduction of the different pediocin-like immunity genes into a highly bacteriocin-sensitive Lb. sakei strain resulted in a selective immunity against the respective pediocin-like bacteriocins tested. In general, low cross-immunity was observed; however, PedB and the immunity protein for sakacin P displayed complete cross-immunity despite the degree of sequence similarity between these two immunity proteins is lower than that observed between, for instance, PedB and the enterocin A immunity protein. 107 The pedC gene encodes a 174 amino acid protein (PedC), which is essential for pediocin secretion in pediococci and E. coli, 55 and belongs to the group of so-called "accesory proteins" required for secretion processes involving ATPbinding cassettes (ABC) transporters. Accesory proteins are also called "membrane fusion proteins" (MFP) because it has been postulated that they may connect the inner and outer membranes of Gram-negative bacteria to facilitate the passage of substrates. 108 The PedC structure is similar to those of HlyD, a protein required for secretion of the E. coli hemolysin A, 109 and LcnD, a protein involved in lactococcin A transport. 110 Finally, pedD encodes PedD, a 724 amino acid ABC transporter dedicated to pediocin secretion through the membrane of the producing cells. Inactivation of this gene leads to total loss of antimicrobial activity because of lack of secretion. 22 The PedD sequence displays a high degree of homology with sequences of many others ABC transporters. 105 
D. Secretion and Maturation of Pediocin PA-1
The secretion and maturation processes of pediocin PA-1 depend on the membrane proteins PedC and PedD, which together form a type I secretion system. 111 In this sec-independent system, the substrate is directly secreted from the cytoplasm of the cell to the extracellular environment. As type I secretion systems are specific for a protein or family of closely related proteins, they are often called "dedicated" transport systems. 112, 113 A typical ABC transporter probably functions as an homodimer, each part consisting of a hydrophobic integral membrane domain and two ATPbinding domains, which can be fused in a multidomain protein. 113 All transporters dedicated to "double glycine" prebacteriocin secretion have an N-terminal cytoplasmic extension that forms the proteolytic domain responsible for removal of the leader peptide. In the N-terminal part of these bacteriocins transporters there are two conserved motifs, the cysteine motif (QX 4 D/ECX 2 AX 3 MX 4 Y/ FGX 4 I/L) and the histidine motif (HY/FY/VVX 10 I/ LXDP). 4, 105 Based on the work of Havarstein et al., 105 with lactococcin G, the following hypothesis for the export of pediocin PA-1 can be made. 4 The proteolytic domain of PedD binds to prepediocin PA-1. Then, hydrolysis of ATP induces conformational changes in PedD leading to an integrated process in which removal of the pediocin leader concomitantly occurs with pediocin translocation across the cytoplasmic membrane. In fact, expression of only the N-terminal 172 amino acids of PedD in E. coli cells producing prepediocin showed that this domain was enough and essential for prepediocin processing. 55 Under these circumstances, mature pediocin could only be found intracellularly, which suggests that the cleavage process can be uncoupled from secretion.
Apart from the extended N-terminal domain responsible for the processing of the prebacteriocin into the mature form, the ABC transporters dedi-cated to double glycine leader bacteriocins probably also differ from the earlier described "classical" ABC transporter proteins in their membrane topology. It has been reported that the lactococcin A-dedicated ABC transporter (LcnC) has four transmembrane segments (TMSs) instead of the six typically present in the classical ones. 113 The accesory protein (PedC) has a membrane topology similar to LcnD, the lactococcin A accesory protein. Both are bitopic proteins with a short N-terminal cytoplasmic part, a transmembrane segment and a large extracellular C-terminal part. 113 Venema et al. 55 speculated that PedC may be involved in channel formation between the cytoplasmic membrane and the cell wall of pediocin-producing cells. A similar role has been proposed for LcnD. 113 Recently, LcnD was shown to be present in two forms: a 52-kDa full-length form, totally contained in the cytoplasmic membrane, and a smaller form (LcnD*, 38 kDa) that is present mainly in the cytoplasm with a small amount localized in the membrane. 114 LcnC and LcnD are organized in a membrane-associated complex in which LcnD, probably present as a dimer, is able to interact with LcnD* and LcnC. 114 In addition, LcnC cross-links with a small peptide that could be the bacteriocin lactococcin A. 114 
E. Heterologous Expression of ped Genes
Heterologous expression systems are usually employed to elucidate the function of recombinant proteins or peptides or to achieve levels of production higher than those of the native sources. They are also useful to produce a protein or a peptide by specific species, or strains, that are better adapted than the native producer to the environment where application of the proteinaceous compund is desired.
Escherichia coli has long been the primary prokaryotic host for cloning genes and expressing recombinant proteins because it is well characterized, many of its biological processes are understood and there are many genetic tools readily available for its manipulation. 115 Regarding pediocin PA-1, transformation of E. coli strains with a plasmid containing the pediocin operon resulted in correct expression of the pediocin genes since the transformants produced zones of inhibition on the indicator lawn. 22 As bacteriocin activity was also observed in cell-free supernatants, the authors concluded that pediocin was, most probably, secreted by the cells. E. coli mutants with a mutated pedD gene did not secrete pediocin, which confirmed the role of PedD in pediocin transport.
In the absence of pedC and pedD, mature pediocin PA-1 can be secreted in an active form when fused to the MBP C-terminus and therefore coupled to the E. coli sec machinery. 96 The chimeric protein was released into the culture medium because it was expressed in a leaky E. coli host in which the gene encoding the outer membrane murein lipoprotein had been disrupted.
Although there is a wealth of tools for exploiting E. coli for heterologous gene expression, other bacteria can offer advantages either for cytoplasmic production, secretion, or surface display. 116 Some LAB species, such as L. lactis are proving to be very versatile, and continuing basic research on gene expression in these organisms will increase their utility as alternative hosts for heterologous gene expression. In addition, many LAB species or strains are food-grade organisms, making them potentially useful for the heterologous (in situ) production of commercially important proteins or peptides. 115 An attractive possibility for heterologous production of pediocin PA-1 is to exploit the significant amino acid homologies in both the leader peptides and dedicated transporters of most class II bacteriocins, some lantibiotics, and also colicin V produced by E. coli. 55, 104, 105 Allison et al. 117 showed that both peptides of the two-component lactacin F complex can use the bacteriocin secretion machinery of Carnobacterium piscicola LV17, a strain that produces carnobacteriocins A, BM1, and B2. 118 The fact that the leaders of these carnobacteriocins and both lactacin F peptides share the highest degree of homology among class II bacteriocins may have facilitated the secretion of the lactacin F peptides in this heterologous host. van Belkum et al. 119 recently demonstrated the flexibility of the translocation apparatus by exchanging the leader peptides of different class II bacteriocins. Gene fusions were generated in which sequences encoding the leader peptides of leucocin A, lactococcin A, and colicin V were fused to divergicin A, a bacteriocin that is secreted through the sec pathway. 120 The different leader peptides were able to direct the secretion of divergicin in Leuconostoc gelidum, L. lactis, and E. coli, respectively (i.e., the homologous hosts). Furthermore, certain leader-translocator combinations led to heterologous production of divergicin. Colicin V was also secreted from L. lactis when it was fused to the leucocin A leader and the lactococcin A secretion machinery was used. However, in some cases, the leader peptides were unable to direct divergicin secretion, suggesting that the various components of the translocation apparatus of class II bacteriocins are not universally interchangeable. It may be that the hydrophobicity of the heterologous peptide plays an important role in the secretion process. 119 Although the system LcnC/LcnD can secrete a great variety of bacteriocins that differ quite drastically (like lactococcins A, B, and M/N), 111 its inability to direct secretion of leucocin A in L. lactis has also been reported. 121 Pediocin PA-1 is a bacteriocin with a broad inhibitory spectrum and is particularly effective in preventing the growth of L. monocytogenes, a major concern in the dairy industry because it can grow in a variety of dairy products at low temperature and pH. However, with the exception of Lb. plantarum WHE 92, 17 all pediocin PA-1-producing bacteria so far isolated are pediococci, organisms usually associated with vegetable and meat substrates but poorly adapted for growing in milk and dairy products. Therefore, the production of pediocin PA-1 in strains of dairy origin is highly desirable.
The four ped genes were cloned into a lactococcal vector and introduced into L. lactis IL1403, a pediocin PA-1-resistant, plasmid-free strain that does not produce bacteriocin but harbors chromosomal genes analogous to those encoding the lactococcin A secretion apparatus (lcnC and lcnD). 55, 122, 123 Secretion of pediocin PA-1, directed by its own leader sequence, was detected only when the ped operon was under the control of the strong lactococcal promoter P32. Even under these conditions, the pediocin yield was less than 1% of the production level by the Pediococcus parental strain. It was possible to increase the relative pediocin PA-1 production level to approximately 50% in L. lactis LL108, a derivative of L. lactis MG1363, by increasing the copy number of the plasmid-encoded ped operon. In the same work, 122 a recombinant P. acidilactici strain was obtained that produced and secreted both active pediocin PA-1 (an amount similar to that of the parental pediococcal strain) and lactococcin A (twofold lower than that of the parental lactococcal strain).
Pediocin PA-1 and lactoccoccin A are both class II bacteriocins and, hence, likely candidates for expression and secretion in L. lactis via heterologous translocators. 38 A hybrid gene specifying an in-frame fusion of the lactococcin A leader and pediocin PA-1 38 was introduced in L. lactis IL1403 (LcnC' + , LcnD' + ). The L. lactis IL1403 derivative produced extracellular pediocin activity, but the production level was approximately 25% of that of the parental pediococcus strain. Significant reductions in the yield of lactococcin A expressed in IL1403 have been described previously. 36, 80 These reductions may be attributed to the low copy number of the chromosomal lcnC'D' genes 123 and/or to differences in the lactococcin A translocation apparatus, 119, 123 resulting in less efficient secretion.
Enhanced heterologous production of pediocin PA-1 was obtained by introducing the lcnC and lcnD genes into the lactococcin A leader-pediocin PA-1 expression system previously developed. 39 When lcnC and lcnD were present on the same plasmid (a pSH71 derivate, 50 to 60 copies per cell 124 ) as the hybrid gene, one of the resulting L. lactis IL1403 derivatives attained pediocin PA-1 levels similar to that of the natural producer P. acidilactici 347. The yield of LcnC/D-mediated translocation of pediocin PA-1 was strongly influenced by the plasmid dosage and by the particular lactococcal strain employed as a production host. It has also been demonstrated that heterologous production of other class II bacteriocins can increase at least 10-fold when the dedicated lcnC and lcnD genes are included in equivalent lactococcal expression systems. 80, 123 In the same study, 39 L. lactis strains with the ability to express and secrete nisin A together with pediocin PA-1 were also constructed, which represents a first step in the construction of LAB strains that coproduce two or more well-characterized widespectrum bacteriocins. Recently, low-level coproduction of the nonsynergistic class IIa bacteriocins pediocin PA-1 and enterocin A in L. lactis IL1403 125 and production of a variable amount of pediocin PA-1 in E. coli, L. lactis, Streptococcus thermophilus, and Enterococcus faecalis have also been achieved. 126 The cells were transformed with shuttle vectors containing the four genes of the ped operon (without its own promoter) behind the S. thermophilus promoter ST P2201 .
Yeast, especially Saccharomyces cerevisiae and Pichia pastoris, are major hosts employed in the expression of heterologous proteins of high quality in the biopharmaceutical, industrial, and academic environments because they combine well-known techniques for the molecular manipulation of prokaryotes with the authenticity of eukaryotic systems. 127 Frequently, excessive amounts of sulfur dioxide and other chemical preservatives are used to prevent growth of undesirable bacteria during the making of wine, beer, and other beverages. This practice affects the quality of the end-products and raises increasing consumer concerns. Schoeman et al. 128 investigated the feasibility of controlling spoilage bacteria during yeast-based fermentations by expressing pediocin PA-1 in S. cerevisiae. To achieve this objective, the pedA gene was inserted into a yeast expression/secretion cassette in which expression of pedA was under the control of the yeast alcohol dehydrogenase I gene (ADH1) promoter and terminator, and the secretion of the bacteriocin was directed by the secretion signal of the yeast mating pheromone α-factor (MFα1 S ). The construct was introduced as a multicopy plasmid in S. cerevisiae. Northern blot analysis confirmed that pedA was efficiently transcribed, while biologically active bacteriocin was detected in a bioassay. However, the heterologous peptide was present in relatively low levels in the yeast culture supernatant because most of the bacteriocin molecules were attached to the yeast cells. Production of extracellular pediocin PA-1 by recombinant yeast strains may be optimized by enhancing pedA gene expression as well as by increasing the secretability of the recombinant bacteriocin. It has been reported that S. cerevisiae is often limited as an expression system by low yields, while other yeast species, such as P. pastoris or Hansenula polymorpha, retain all the advantages of S. cerevisiae and provide a reliable means of achieving greatly elevated yields. [129] [130] [131] The development of systems for heterologous production of pediocin PA-1 and other bacteriocins, either using ABC-transporters or sec-dependent secretion systems, may contribute to overcome problems that bacteriocin-producing starter cultures often face in food processes, such as poor adaptability, low production, or genetic instability. In addition, these heterologous systems could be used for production of hybrid bacteriocins or pediocin-like bacteriocins with improved properties obtained by protein engineering. Overexpression of the ped genes by use of food-grade inducible systems, like those based on the PnisA promoter [132] [133] [134] [135] or the salt-inducible Pgad promoter 136, 137 could be another interesting approach. Recently, enhanced secretion of pediocin PA-1 was achieved in a L. lactis strain following induced expression of pedC and pedD behind the Pgad promoter. 138 
F. Factors Affecting Pediocin PA-1 Biosynthesis
The amount of pediocin PA-1 produced is very strain-dependent, although the variability seems to be less than that observed, for instance, among different nisin-or leucocin Lcm1-producing strains. 139 Under the same conditions, P. acidilactici H produced more pediocin than strains E, F, and M, 100 which was attributed to the higher growth rate of strain H and/or to the higher genetic stability of the plasmid on which the pediocin operon is located in that strain. The level of pediocin PA-1 produced by Lb. plantarum WHE 92 was higher than that of P. acidilactici H under optimum culture conditions, although production per cell was not reported. 17 Recently, specific antibodies were used to determine the concentrations of pediocin PA-1 in the supernatants of five independently isolated P. acidilactici strains. 41 While four of the strains produced similar amounts (ranging from 1946 to 2200 ng ml -1 ), the bacteriocin con-centration in the supernatants of the remaining strain was significantly lower (12 ng ml -1 ).
Pediocin PA-1 production is higher when the producing pediococci are grown at 30 to 37°C 50 in media that allow the development of a high cell mass and a high acidity, such as MRS or TGE. 50, 139, 140 The addition to TGE broth of supplements (tryptone, glucose, yeast extract) or complements (niacinamide, panthotenic acid, biotin) that stimulate cellular proliferation notably increased pediocin production, while production decreased by incorporating buffering compounds. 139 A clear reduction in the quantity of pediocin produced either by P. acidilactici strains or Lb. plantarum WHE 92 was observed when the final pH of the medium exceeded 4.0. 17, 141 While bacteriocin production by P. acidilactici H was neligible when the pH of the medium was 5 and ceased at pH 5.5, even at high cell densities, 17, 140 the activity of culture extracts from Lb. plantarum WHE 92 remained constant independently of the final pH value of the culture broth between pH 4.0 and 6.0 at pH and decreased only at pH 6.5. 17 A later study confirmed that the amount of pediocin PA-1 produced by Lb. plantarum WHE 92 at the end of the exponential growth phase is independent of the pH of the culture medium between pH 4.0 and 6.0. 141 It has been suggested that processing of prepediocin to active pediocin by pediococci takes place efficiently only if the pH of the medium is less than or equal to 5.0. 139, 142 Although this would explain why pediocin production by P. acidilactici decreases when the final pH of the culture is higher than 5, it is not clear why that of Lb. plantarum WHE 92 is not reduced up to pH 6.0. 17 Culture pH may have played an important role in the yield of pediocin PA-1 by the heterologous lactococcal host L. lactis FI9043, because larger inhibition zones were generated from supernatants of cultures grown in MRS broth (final pH 4.6) than from those in GM17 broth (final pH 5.3). 38 The highest pediocin yields can be obtained by determining the optimal conditions for pediocin production during pH-and temperature-controlled batch cultures in a fermentor. 141, 143 Under such conditions, batch cultures of P. acidilactici UL5-T5 at 37°C and pH 5.5 yielded approximately 190 mg l -1 of pediocin.
V. TOXICITY
Pediocin-producing strains are found in a variety of natural foodstuffs, such as meat products, 8, 10, 19, 34 dairy products, 17 and vegetables. 18 Therefore, they (and most probably pediocin too) have been ingested by human consumers for centuries without apparent adverse effects, which is a first indication of low toxicty of this bacteriocin toward eukaryotic cells. Additionally, treatment of mouse myeloma cell cultures with pediocin PA-1 did not affect cellular viability or morphology, 50 and no detrimental effects have been observed after subcutaneous, intradermic, intravenous, or intraperitoneal administration of this bacteriocin (or fragments thereof) to mice and rabbits 14, 40, 41, [144] [145] [146] or after prolonged ingestion by humans of meat products made with the pediocinproducing strain P. acidilactici H. 147 Finally, the intestinal microflora is probably unaffected by pediocin PA-1 because of its inactivation by the proteolytic enzymes of the digestive tract.
VI. IMMUNOLOGICAL PROPERTIES
In general, generation of antibodies against bacteriocins may provide sensitive and specific tools for the detection of producing strains and for the quantification of the peptides in culture media and food extracts by immunochemical assays. 40, 41, 43, 145, 146, [148] [149] [150] Moreover, antibodies may be used in single-step purification methods based on immunoaffinity strategies. 44 Although highly specific immunochemistry-based methods have been developed and routinely used as analytical tools in many research areas, their impact in the bacteriocin research field has been marginal. 149 Thus, identification and detection of bacteriocinogenic LAB and bacteriocins has relied on the use of sensitive but unspecific bioassay-based tests.
The two main difficulties encountered in raising antibodies against bacteriocins are the lack of commercially available purified bacteriocins and the need to couple them to proper carrier proteins because of their low molecular masses (which make them poorly immunogenic or nonimmunogenic). In addition, some characteristics of class II LAB bacteriocins such as hydrophobicity or the pres-ence of intrachain disulfide bonds may interfere with the development of sensitive immunoassays.
Bhunia et al. 144 evaluated the immunogenic properties of partially purified pediocin by immunizing mice and a rabbit and found that it was unable to illicit an antibody response, even after conjugation of the peptide to bovine serum albumin. Polyclonal and monoclonal antibodies against pediocin were developed by immunizing mice for 12 weeks with pediocin conjugated to a polyacrylamide matrix. 148 Among 230 hybridoma clones generated after two fusions, two were found to produce antibodies that in Western immunoblots recognized this bacteriocin (detection limit: 10 µg ml -1 ) but did not react with sakacin A, leuconocin LCM1, nisin and pediocin A. Immunization of mice with crude precipitates of pediocin PA-1 or with pediocin bound to heat-killed Lactobacillus plantarum cells failed to produce antibodies against the bacteriocin. In colony immunoblot assays, the monoclonal antibodies were used to differentiate Ped + and Ped -variants of P. acidilactici RS2. Although monoclonal antibodies could be very useful in developing quantitative assays for pediocin production, to date no new developments have been reported from this line of research.
Development of successful polyclonal and monoclonal antibodies and immunoassay formats have enabled the sensitive and specific detection and quantification of nisin. 43, 44, 149, 150 Commercial preparations of pure pediocin PA-1, unlike nisin, are not available, and current pediocin PA-1 purification protocols do not allow purification of the large quantities of peptide needed to carry out cost-efficient immunization protocols. The use of whole bacteriocins, either alone or conjugated to carrier proteins may, if successful, lead to the generation of unspecific polyclonal antibodies due to cross-reactivity with consensus amino acid sequences found in other bacteriocins, and especially among class IIa LAB bacteriocins. 4, 26, 151 Short peptide fragments of proteins can be used to generate antibodies that frequently recognize the folded protein from which the peptide sequence was derived, 152 a fact that explains why antipeptide antibodies have become important tools in many research fields. 153, 154 Chemically synthesized fragments selected from the amino acid sequence of pediocin PA-1 could, thus, potentially facilitate obtaining antibodies of predetermined specificity for the recognition of the native peptide molecule. 145 Recently, such polyclonal antibodies against pediocin PA-1 have been generated by immunization of rabbits with a chemically synthesized C-terminal fragment (PH2, residues 34 to 44) conjugated to the carrier protein keyhole limpet hemocyanin (KLH). 40 The limits of detection of pediocin PA-1 in MRS medium using these antibodies were approximately 2.5, 1, 0.025 and <0.025 µg ml -1 by immunodotting, noncompetitive indirect ELISA (NCI-ELISA), competitive indirect ELISA (CI-ELISA) and competitive direct ELISA (CD-ELISA), respectively. All immunoassays and the slot-dot assay detected the bacteriocin in the supernatant of the producer P. acidilactici 347. The antibodies did not crossreact with other bacteriocins, including other members of class IIa LAB bacteriocins, and were very useful in demonstrating heterologous production of pediocin PA-1 in L. lactis. 38, 125 Pediocin PA-1-specific rabbit polyclonal antibodies have also been generated with a synthetic 1 to 9-N-terminal fragment (PH1) conjugated to the same carrier protein. 41 In this case, the limits of detection of pediocin PA-1 in MRS medium were approximately 5, 0.5, 0.01, and <0.01 µg ml -1 by protein slot-blotting, NCI-ELISA, Western blotting, and CI-ELISA, respectively. The amount of free pediocin required for 50% binding inhibition was 0.1 µg ml -1 as determined by CI-ELISA. In addition, results obtained with the same assay clearly indicated that when pediocin, instead of ovalbumin-conjugated pediocin, was used as solid-phase antigen, the assay was notably better. In contrast, pediocin did not efficiently compete with the conjugate pediocin-horseradish peroxidase for binding to antibody-coated microtiter plate wells in CD-ELISA, confirming the results of previous work 145 and highlighting the importance of the selection of proper immunoassays for bacteriocin detection. The PH1-KLH polyclonal antibodies detected the peptide in the supernatants of five pediocin-producing P. acidilactici strains. 41 However, it did not or only slighty reacted with supernatants of LAB strains producing enterocin A, enterocin P, sakacin P, or sakacin A, bacteriocins that contain the longer (KYYGNGVxC) or shorter (YGNGVxC) consensus amino acid sequence present in pediocin PA-1. This result is not surprising because it has been shown that, within a peptide fragment, changes in a single amino acid residue can drastically affect protein recognition. 155 The conjugate PH2-KLH has also been used to immunize mice in order to obtain a source of pediocin PA-1 monoclonal antibodies. However, among the hybridomas generated after three fusions, none produced antibodies. 146 
VII. FOOD APPLICATIONS
Although frequently in vitro studies have shown the high antimicrobial activity of pediocin PA-1 against sensitive bacteria, particularly L. monocytogenes strains, most food applications of this bacteriocin have resulted in relatively modest reductions of 1 to 3 log cycles in the populations of potential foodborne pathogens. 45 Therefore, deductions obtained from in vitro challenges should not be extrapolated to predict pediocin efficacy in a food matrix. 156 Factors that may lead to a reduction of pediocin activity in foods include those affecting the pediocin-producing strain (such as inadequate environment, spontaneous loss of the bacteriocin-producing ability, phage infection, or antagonism by other microorganisms) and those affecting the bacteriocin action (such as emergence of bacterial resistance, bacteriocin binding to food components, or poor solubility or stability in the food substrate). 45, 156, 157 Although the levels of bacterial population reduction achieved by pediocin PA-1 in foods may preclude its consideration as a primary preservation method, this bacteriocin and/or the producing strains could be very useful as an additional safety factor contributing to the "hurdle" or "barrier" approach for preservation of foods. 7, 45 In this kind of food preservation systems, the combined effects of intrinsec (e.g., pH, heat treatment, salt, sugar, chemical additives) and extrinsic (e.g., storage conditions) inhibitory barriers work synergistically to extend storage life and ensure the microbiological safety of foods. 158 Currently, the incorporation of pediocin or other LAB bacteriocins to this approach is attractive because the range of minimally processed foods available in the marketplace is rapidly increasing. 7 
A. Meat and Meat Products
Kalchayanand 159 studied the action of pediocin PA-1 (1,400 AU ml -1 ) added to beef meat inoculated with food-spoilage strains of Clostridium laramiae, Lactobacillus spp., and Leuconostoc. Subsequently, the meat samples were vacuumpackaged and stored in refrigeration. Under these conditions, the treated samples remained unaltered after storage for 12 weeks and the population levels reached by the spoilage bacteria were significantly lower in the samples containing the bacteriocin than in the respective control samples. Simultaneously, another study 160 evaluated the ability of pediocin PA-1 (500 to 5000 AU ml -1 ) to prevent the adhesion of L. monocytogenes to irradiated beef meat and to decontaminate the meat inoculated with 10 2 to 10 4 cfu g -1 . Both strategies reduced the populations of L. monocytogenes between 1.2 and 2 log cycles, and the residual bacteriocin activity was detected on the meat surface for at least 28 days at 5°C.
Berry et al. 161 employed the pediocin-producing strain P. acidilactici JD1-23 as starter culture for the elaboration of meat products and found that it provided a 2-log reduction in added L. monocytogenes (10 6 cfu g -1 ) during summer sausage production, which are results similar to those obtained by Foegeding et al. 162 However, after storage for 2 weeks, 10% of the sausages were Listeria-positive, a result contributing to the current concern for the potential presence of this foodborne pathogen in ready-to-eat foods, even if the initial levels are much lower in most of the cases. Later, Berry et al. 163 showed that coinoculation of P. acidilactici JD1-23 and L. monocytogenes in frankfurters, followed by vacuum packaging and storage at 4°C, prevented the growth of the pathogen for at least 60 days.
Yousef et al. 164 compared the ability of pediocin PA-1 and a pediocin-producer to control the growth of three L. monocytogenes strains in wiener sausage exudates and showed that both approaches significantly decreased their growth under refrigerated (4°C) and abusive (25°C) temperature conditions. Although the decrease in Listeria populations was faster when adding the bacteriocin, lower final levels were achieved using the producing strain. Similar findings were obtained by Degnan et al. 165 Surface inoculation of wiener sausages with L. monocytogenes and a pediocin-producing Pediococcus strain, packaging and storage at 4 and 25°C revealed that, in this case, the producer was unable to grow or produce the bacteriocin at 4°C, while reductions of up to 3.4 logs in Listeria levels were observed at 25°C. 12 Motlagh et al. 62 examined the effectiveness of pediocin PA-1 in reducing the population of three Listeria strains in sterile ground beef, sausage mix, Cottage cheese, ice cream, and reconstituted dry milk and observed that the bacteriocin action was immediate and was not affected by the food system tested. In addition, these authors showed that the activity was concentration and strain dependent. For example, 1350 AU ml -1 of pediocin reduced the population of L. monocytogenes ScottA, L. monocytogenes Ohio2, and L. ivanovii ATCC 19119 in 1, 3, and 7 log cycles, respectively. A listericidal effect (approximately 7 log cycles) has been observed in slurries prepared from vacuum-packaged ready-to-eat turkey breast meat and challenged with L. monocytogenes in the presence of diacetate and pediocin. 166 The increased antilisterial activity in slurries with diacetate in combination with the bacteriocin were due to synergistic effects. The listericidal activity of pediocin PA-1 has also been evaluated in slurries of beef muscle tissue, beef tallow, nonfat dry milk, and butterfat inoculated with a mixture of two L. monocytogenes strains. 167 For all slurries tested, the greatest decrease in Listeria counts (1.2 to 1.8 log cycles) occurred within 1.5 min of pediocin addition. In the same study, pediocin was also encapsulated within phosphatidyl-choline-based liposomes before addition to the slurries or unencapsulated in slurries containing the emulsifier Tween 80. In both cases, the pediocin activity recovered from the slurries was notably higher than that obtained after adding free pediocin PA-1. Cold storage of L. monocytogenes-inoculated pork in the presence of pediocin resulted in a 2 log reduction after 24 h when compared with untreated controls, regardless of whether the samples were stored under air, vacuum, or a modified atmosphere. 168 Goff et al. 64 bound pediocin PA-1 to heatkilled producer cells by adjusting the pH of the medium to 6.0 and the preparation was added to irradiation-sterilized raw chicken breast meat. The results suggested that pediocin-treated raw chicken exhibits antilisterial activity both before and after cooking, and therefore may provide protection to consumers against bacterial postprocessing recontaminations and/or undercooking. Application of pediocin to food packaging films may constitute an alternative approach to control L. monocytogenes in meats and poultry. Ming et al. 169 obtained a pediocin PA-1 extract from milkbased media and prepared antilisterial cellulose casings by internal coating with the pediocin podwer (7.75 µg cm -2 ). The coated bags completely inhibited growth of inoculated L. monocytogenes through 12 weeks storage at 4ºC.
B. Milk and Dairy Products
Inhibition of L. monocytogenes has been demonstrated in several dairy systems, including dressed Cottage cheese, half-and-half cream, and cheese sauce. 53 In all these food systems, there was a rapid decrease in viable counts of L. monocytogenes in the presence of pediocin PA-1 podwer over the pH range 5.5 to 7.0 and at both 4 and 32°C. Although a resurgence of the pathogen after 7 days at 4°C in the midly acidic and neutral dairy systems was described, decreases in Listeria populations of at least 2 log cycles were observed in such substrates. As cited above, Motlagh et al. 62 and Degnan et al. 167 also reported the antilisterial activity of pediocin PA-1 in dairy products.
Despite the fact that pediococci are poorly adapted to dairy substrates, it has been reported that different pediocin-producing P. acidilactici strains may contribute to L. monocytogenes control in milk when a very high inoculum (10 9 cfu ml -1 ) is used. 170 In contrast, the pediocin producer Lb. plantarum WHE 92 was originally isolated from a smear-surface soft cheese 17 and, therefore, it must be well-adapted to this dairy environment.
In fact, the presence of L. monocytogenes in Munster cheese could be prevented by spraying a cell suspension of Lb plantarum WHE 92 on the cheese surface at the begining of the ripening period. 141 Although L. monocytogenes was sometimes detected at low levels (<50 cfu g -1 ) after 7 to 11 days of ripening, this microorganism was unable to grow or survive in the presence of the bacteriocin-producing strain in any of the samples examined until the end of ripening (21 days). The pathogen often reached counts higher than 10 4 cfu ml -1 in control samples. Lb. plantarum WHE 92 did not interfere with the ripening process.
The L. lactis LL108 strain producing pediocin PA-1 122 lacks several properties required for application in milk and dairy products. 171 Therefore, in order to fully exploit the commercial potential of a pediocin-producing dairy starter culture, L. lactis MM210, a strain that had been used previously in Cheddar cheese manufacturing, was selected as an alternative host for the ped operon-encoding plasmid. 171 The antilisterial ability of the pediocinproducing L. lactis starter culture was tested in Cheddar cheeses coinoculated with the lactococcal strain and a mixture of three L. monocytogenes strains. 171 In the experimental cheese, the counts of the pathogen decreased by 1 log cycle within 1 week of ripening and then decreased by an additional log cycle within 3 months (final counts: 10 cfu g -1 ). In control cheeses made with an isogenic, nonpediocin-producing L. lactis strain, Listeria counts increased by approximately 4 log cycles after 2 weeks of ripening and then gradually decreased to about 10 3 cfu g -1 after 6 months. The presence of the plasmid encoding heterologous pediocin production in the lactococcal starter culture did not affect its cheese-making quality.
C. Other Foodstuffs
With respect to other foodstuffs, the addition of pediocin PA-1 to liquid whole egg containing L. monocytogenes showed an immediate reduction in listerial counts and led to a greater reduction (of up to 1 log cycle) during heating when compared with the levels found after heating untreated liquid whole egg. 45 The addition of pediocin PA-1 during fermentation of a vegetable (kimchi) also notably decreased L. monocytogenes counts and inhibited its growth during a minumum of 16 days. 172 
D. Legal Status
Up to date, nisin has been the only bacteriocin licenced as food preservative, although the antimicrobial potential of pediocin PA-1 has already been commercially exploited as a pediocin PA-1-containing fermentate. Owing to their typical association with food fermentation and their long tradition as food-grade bacteria, pediocin PA-1-producing LAB are "generally recognized as safe" (GRAS), and therefore the benefits of this bacteriocin can already be exploited using the producer strains or their fermentates, a practice for which special labeling would not be required. 173 In fact, a wide use of bacteriocin-producing LAB in food fermentations has inadvertently or empirically been made for centuries, and it seems clear that bacteriocin residues are present in our daily food supply. 7 Currently, there are some European and US patents covering the use of pediocin PA-1 in dairy 174 and meat products. 175, 176 
VIII. CONCLUSION AND FUTURE PROSPECTS
Many LAB bacteriocins have been identified over the years 1 but only nisin, and pediocin PA-1 have been examined extensively in application studies in food systems. Although pediocin PA-1 has an antimicrobial spectrum not as wide as that of nisin, it is generally more active against Listeria monocytogenes. The fact that this microorganism is of special concern to the food industry, because of the high mortality and morbidity rates associated with listeriosis, 45 may help to increase the use of pediocin PA-1 as a food biopreservative.
Pediocin PA-1 has been the subject of considerable interest in recent years. However, there are still many aspects that need further research. Its three-dimensional structure and mode of action are far from completely elucidated. The establishment of the relationships between its structure and its biological activity will be of particular interest because this knowledge may facilitate the enhancement of pediocin PA-1 activity and a greater understanding of the mechanisms of bacterial resistance to the peptide. Protein engineering, genetic engineering, and/or chemical synthesis may lead to the development of new antimicrobial peptides with improved properties, based on some features of the pediocin PA-1 molecule (pediocin PA-1 variants, hybrid bacteriocins). The use of genetically modified organisms for the in situ production of pediocin PA-1 may meet with opposition from industries and/or consumers. Therefore, the development of (inducible) "food-grade" genetic systems for pediocin PA-1 production would be highly relevant. Enhancement of the pediocin PA-1 productivity when it is heterologously (co)produced by starter cultures may contribute to widen the applicability of pediocin PA-1 in foodstuffs.
The approval of pediocin PA-1 as a food additive would require the existence of methods that allow the specific detection of this bacteriocin in foods. The recent development of specific polyclonal antibodies is a promising step in this direction. Specific antibodies could also facilitate the (industrial scale) purification of pediocin PA-1 through the use of immunoaffinity columns.
Inasmuch as different laboratories worldwide are working on the elucidation of all these points, we are confident that pediocin PA-1 or pediocin PA-1-like peptides will be included in the next generation of food preservatives.
